Mohanram Narayanan MD, FACP, FASN, FNKF,FRCP (C) Reference List Abstract

Similar documents
Nimrit Goraya, MD Reference List

SELECTED ABSTRACTS. All (n) % 3-year GS 88% 82% 86% 85% 88% 80% % 3-year DC-GS 95% 87% 94% 89% 96% 80%

Efficacy and Safety of Thymoglobulin and Basiliximab in Kidney Transplant Patients at High Risk for Acute Rejection and Delayed Graft Function

BK virus infection in renal transplant recipients: single centre experience. Dr Wong Lok Yan Ivy

BK Virus (BKV) Management Guideline: July 2017

European Risk Management Plan. Measures impairment. Retreatment after Discontinuation

How do the KDIGO Clinical Practice Guidelines on the Care of Kidney Transplant Recipients apply to the UK?

Long-term prognosis of BK virus-associated nephropathy in kidney transplant recipients

Intravenous immunoglobulin in BK virus nephropathy

Chapter 6: Transplantation

Kidney Transplantation in the Elderly. Kristian Heldal, MD, PhD Telemark Hospital Trust, Skien, Norway and University of Oslo

Clinical Outcomes of Renal Transplantation in Hepatitis C Virus Positive Recipients

Considering the early proactive switch from a CNI to an mtor-inhibitor (Case: Male, age 34) Josep M. Campistol

2017 CST-Astellas Canadian Transplant Fellows Symposium. Management of Renal Dysfunction in Extra Renal Transplants

BK Viral Infection and Malignancy in Renal Transplantation ~A Case History~

A clear path forward COMING SOON THE LATEST INNOVATION IN KIDNEY TRANSPLANT SURVEILLANCE CAN DRIVE BETTER OUTCOMES FOR YOUR PATIENTS

Cardiovascular Risk Reduction in Kidney Transplant Recipients

Persistent post transplant hyperparathyroidism. Shiva Seyrafian IUMS-97/10/18-8/1/2019

Literature Review Transplantation

ABO-incompatible kidney transplantation in elderly patients over 60 years of age

Kidney Allograft Stone after Kidney Transplantation and its Association with Graft Survival

Post-Transplant Monitoring for the Development of Anti-Donor HLA Antibodies

Cases: CMV, HCV, BKV and Kidney Transplantation. Simin Goral, MD University of Pennsylvania Medical Center

REACH Risk Evaluation to Achieve Cardiovascular Health

A clear path forward AVAILABLE NOW THE LATEST INNOVATION IN KIDNEY TRANSPLANT SURVEILLANCE CAN DRIVE BETTER OUTCOMES FOR YOUR PATIENTS

Donor-derived Cell-free DNA Improves DSA-informed Diagnosis of ABMR in Kidney Transplant Patients

Management of Rejection

Risk factors in the progression of BK virus-associated nephropathy in renal transplant recipients

What is the Best Induction Immunosuppression Regimen in Kidney Transplantation? Richard Borrows: Queen Elizabeth Hospital Birmingham

Transplantation in Australia and New Zealand

BK virus, kidney transplant, polycystic kidney disease. 1-3 Following mild or asymptomatic primary infection, typically early

Lack of Significant Co-Activation of BKV and CMV in Renal Transplant Patients: An Institutional Experience

Our Experiences in Kidney Transplantation and Monitoring of Kidney Graft Outcomes

Jamalbek Ashimov, Janybek Gaibyldaev SRI of Heart Surgery and Organ Transplantation, Bishkek, Kyrgyzstan

Chapter 22: Hematological Complications

Home Hemodialysis or Transplantation of the Treatment of Choice for Elderly?

Emerging Drug List EVEROLIMUS

Transplant Hepatology

Cover Page. The handle holds various files of this Leiden University dissertation.

clevelandclinic.org/transplant

Progress in Pediatric Kidney Transplantation

PUO in the Immunocompromised Host: CMV and beyond

OUT OF DATE. Choice of calcineurin inhibitors in adult renal transplantation: Effects on transplant outcomes

ABO. ABO ABO ABO ABO ABO ABO ABO ABO. Key words ABO. Alexandre ABO ABO. double filtration plasmapheresis, DFPP. antibody-mediated rejection, AMR

A Retrospective Comparison of the Safety and Efficacy of 3 months vs. 6 months

For Immediate Release Contacts: Jenny Keeney Astellas US LLC (847)

Long-term complications after kidney transplantation. Adnan Sharif

The recovery status from delayed graft function can predict long-term outcome after deceased donor kidney transplantation

Pathological back-ground of renal transplant pathology and important mile-stones of the Banff classification

HBV, HCV, HIV and Kidney Transplantation. Simin Goral MD University of Pennsylvania Medical Center Philadelphia, Pennsylvania

Kidney transplantation 2016: current status and potential challenges

Recurrent Idiopathic Membranous Glomerulonephritis After Kidney Transplantation and Successful Treatment With Rituximab

Intruduction PSI MODE OF ACTION AND PHARMACOKINETICS

Recognition and Treatment of Chronic Allograft Dysfunction

Postoperative monitoring after

Case Report Beneficial Effect of Conversion to Belatacept in Kidney-Transplant Patients with a Low Glomerular-Filtration Rate

GUIDELINES ON RENAL TRANSPLANTATION

Nephrology Grand Rounds

Increased Early Rejection Rate after Conversion from Tacrolimus in Kidney and Pancreas Transplantation

Belatacept: An Update of Ongoing Clinical Trials

Literature Review: Transplantation July 2010-June 2011

Steroid Minimization: Great Idea or Silly Move?

Overview of New Approaches to Immunosuppression in Renal Transplantation

This study is currently recruiting participants.

Controversies in Renal Transplantation. The Controversial Questions. Patrick M. Klem, PharmD, BCPS University of Colorado Hospital

Transplant Success in Sensitized Patients Receiving a Standardized Desensitization Therapy: 3 Year Outcomes

Impact of Subclinical Rejection on Transplantation

Management of HBV in KidneyTransplanted Patients Dr.E.Nemati

Pranav Dalal, MD, MPH

Trends in immune function assay (ImmuKnow; Cylexä) results in the first year post-transplant and relationship to BK virus infection

Outcomes of living donor kidney transplantation in diabetic patients: age and sex matched comparison with non-diabetic patients

Acute rejection and late renal transplant failure: Risk factors and prognosis

Proton Pump Inhibitors do not Interact with the Immunosuppressant Enteric-Coated Mycophenolate Sodium

Clinical Grand Rounds. May 2016

Five years of living donor kidney transplantation at University clinical center Tuzla, Bosnia and Herzegovina, from 1999 through 2004

Lupus and Your Kidneys. Michael P. Madaio, MD Professor of Medicine Chairman of Medicine Medical College of Georgia Augusta, Georgia

Kidney Transplant Outcomes In Elderly Patients. Simin Goral MD University of Pennsylvania Medical Center Philadelphia, Pennsylvania

CHAPTER 5 RENAL TRANSPLANTATION. Editor: Dr Goh Bak Leong

Pleiotropic effects of mtor inhibitors : cardiovascular and cancer. Dr Paolo Malvezzi Clinique de Néphrologie CHU Grenoble

Serum samples from recipients were obtained within 48 hours before transplantation. Pre-transplant

American Journal of Transplantation 2009; 9 (Suppl 3): S1 S157 Wiley Periodicals Inc.

Reduced graft function (with or without dialysis) vs immediate graft function a comparison of long-term renal allograft survival

Management of End Stage Renal Disease-Bangladesh Perspective

CHAPTER 5 RENAL TRANSPLANTATION. Editor: Dr Goh Bak Leong

Chapter 4: Steroid-resistant nephrotic syndrome in children Kidney International Supplements (2012) 2, ; doi: /kisup.2012.

Renal Transplant Registry Report 2008

Pancreas Transplantation. Sonia Clarke-Swaby Recipient Kidney/pancreas Transplant Co-ordinator Guy s Hospital

Post-operative Care of the Kidney Transplant Recipient

Annual Report Division of Nephrology Department of Medicine, Jewish General Hospital April 1, December 31, 2011

Kidney Transplant. November 4 th, 2016

Prophylaxis of acute transplant rejection in patients receiving allogeneic renal transplants:

Mycophenolate mofetil (MMF) is an effective anti proliferative

Incidence of Rejection in Renal Transplant Surgery in the LVHN Population Leading to Graft Failure: 6 Year Review

The New England Journal of Medicine PROSPECTIVE STUDY OF POLYOMAVIRUS TYPE BK REPLICATION AND NEPHROPATHY IN RENAL-TRANSPLANT RECIPIENTS

CHAPTER 14. Renal Transplantation

Summary of Results for Laypersons

Renal Transplant Past Present and Future David Landsberg

Clinical Practice Guideline Post-Operative Care in the Kidney Transplant Recipient

Ryszard Grenda: Steroid-Free Pediatric Transplantation. Early Steroid Withdrawal in Pediatric Renal Transplantation

Quantification of the Early Risk of Death in Elderly Kidney Transplant Recipients

Transcription:

Abstract Primary Hyperoxaluria Causing ESRD and Lower Extremity Gangrene 662 Nidhi Munshi, Mohanram Narayanan 66E Abstract and Poster presented at the Annual Dialysis Conference March, Orlando, FL. 2008 Effect of Hepatitis C infection on anemia in hemodialysis patients 772 Anand Khurana, Mohanram Narayanan, Allan E Nickel 662Abstract presented at the Spring Clinical Meeting of the National Kidney Foundation, April, Orlando, FL. 2007 Statin Use Improves Survival Post Kidney Transplantation 626 Judson Severson, Luis Concepcion, Mohanram Narayanan 626 Abstract presented at the 40th Annual Meeting of the American Society of Nephrology, Nov. San Francisco, CA (SAPO443) 2007 Post transplant anemia: A single center experience 626 Anand Khurana, Mohanram Narayanan 66E Abstract presented at the Annual Meeting of the Texas Transplantation Society, July, San Antonio, TX. 2006 Retrospective Evaluation and Characterization of Health Care Utilization in a Managed Care Organization for Members with Stage 1, 2, or 3 Chronic Kidney Disease 66E Tonya Martin, Charles Foulks, Barry Browne, Mohanram Narayanan 626 Abstract presented at the 39th Annual Meeting of the American Society of Nephrology, Nov. San Diego, CA (SA-PO337) 2006 Incidence & Risk Factors for Development of Post Transplant Diabetes Mellitus in Renal Allograft Recipients 727 a single center experience 662 Nidhi Munshi, Mohanram Narayanan - Poster and Podium presentation at 99th Annual Scientific Assembly of Southern Medical Association, Nov, San Antonio, TX. 2005 May 21, 2017 1

Abstract Improvement of Bone Density with Alendronate after Renal Transplantation 662 Elena Slavcheva, Charles McCuskey, Mohanram Narayanan, Gregory Jaffers et al 662 Abstract presented at the 3rd American Transplant Congress, May, Washington, D.C. 2003 Treatment of CMV Infection in Renal Transplant Recipients with an Abbreviated Course of IV Ganciclovir - Elena Slavcheva, Gregory Jaffers, Mohanram Narayanan et al 26E Abstract presented at the 35th Annual Meeting of the American Society of Nephrology, Nov., Philadelphia, PA. (SU-P0470) 2002 Book Chapter Narayanan M, Watson RE, DiPette DJ: Hypertension: Evaluation, Therapy & Review of Landmark Trials. In Abela GS, ed. Peripheral Vascular Disease: Basic Diagnostic & Therapeutic Approaches. Philadelphia: Lippincott, Williams & Wilkins, 105-122. 2004 Clark LJ, Kanarvogel L, Narayanan M, Runde M, Smith GA: Internal Medicine Practice Questions Book 1, Vol 1&2 Ed Burday MJ; Medtext Medical Publishing Co. Redondo Beach, CA 1996 Bloom R, Bromberg J, Poggio E, Bunnapradist S, Langone A, Sood P, Matas A, Mehta S, Sharfuddin A, Fischbach B, Narayanan M, et al: Cell-free DNA and Active Rejection in Kidney Allografts. Journal of the American Society of Nephrology. Epub ahead of print March 9, 2017. 2017 Bromberg J, Brennan D, Poggio E, Suphamai B, Langone A, Sood P, Matas A, Mehta S, Sharfuddin A, Fischbach B, Narayanan M, et al: Biological Variation of Donor-derived Cell-free DNA in Renal Transplant Recipients: Clinical Implications. Journal of Applied Laboratory Medicine, Sept. 2017 2017 May 21, 2017 2

Pakanati A, Padooru K, Narayanan M: Role of Cinacalcet in Management of Post Renal Transplant Residual Hyperparathyroidism and Hypercalcemia - Retrospective Chart Review. American Journal of Kidney Disease 2015;65(4):A64 2015 Narayanan M, Pankewycz O, Shihab F, Wiland A, Mccague K, Chan L: Long-term Outcomes in African American Kidney Transplant Recipients under Contemporary Immunosuppression: a Four-Year Analysis of the Mycophenolic Acid Observational REnal Transplant (MORE) Study. Clinical Transplantation 2014;28-(2):184-191 2014 Hatahet M, Narayanan M, Cleaves C, Zreik R: Disseminated Mucormycosis in a Patient with Recent Kidney Transplantation: Case Report and Literature Review. Case Rep Nephrol Urol 2013 May 7;3 (1):58-63 2013 Langone A, Doria C, Greenstein S, Narayanan M, Ueda K, Sankari B, Pankewycz O, Shihab F, Chan L: Does Reduction of Mycophenolic Acid Dose Compromise Efficacy Regardless of Tacrolimus Exposure Level? An Analysis of Prospective Data from the Mycophenolic Renal Transplant (MORE) Registry. Clinical Transplantation 2013;27(1):15-24 2013 Narayanan M, Pankewycz O, El-Ghoroury M, Shihab F, Wiland A, Mccague K, Chan L: Outcomes in African American Kidney Transplant Patients Receiving Tacrolimus and Mycophenolic Acid Immunosuppression. Transplantation 2013;95(4):566-572 2013 Doria C, Greenstein S, Narayanan M, Ueda K, Wiland A, McCague K, Sankari B, Chan L: Associationi of Mycophenolic Acid Dose with Efficacy and Safety Events in Kidney Transplant Patients Receiving Tacrolimus: an Analysis of the Mycophenolic Acid Observational Renal Transplant Registry. Clinical Transplantation 2012;26(6):E602- E611 2012 May 21, 2017 3

Jaffers G, Narayanan M, Fasola C: Surgical Correction of Nephrogenic Ascites in a Renal Transplant Recipient. Experimental and Clinical Transplantation 2012;4:394-397 2012 Narayanan M, Pankewycz O, Shihab F, Wiland A, Mccague K, Chan L: Immunosuppession and Outcomes in African American (AA) Renal Transplant Recipients: A 4-year Analysis from the Mycophenolic Acid Observational Renal Transplant (MORE) Registry. Journal of the American Society of Nephrology Nov. 2012;23:855A-856A 2012 Narayanan M, Pankewycz O, Shihab F, Wiland A, Mccague K, Chan L: Two-Year Outcomes of African American (AA) Renal Transplant Recipients from the Mycophenolic Acid Observational Renal Transplant (MORE) Reistry. American Journal of Transplantation May 2012; Supp 3;12:242 2012 Seerangan G, Narayanan M: A Rare Case of Subarachnoid Hemorrhage due to Rupture of Isolated Anterior Spinal Artery Aneurysm in a Patient with Polycystic Kidney Disease. Case Rep Nephrol Urol 2012;2:108-112 2012 Narayanan M, Pankewycz O, El-Ghoroury M, Shihab F, Wiland A, Mccague K, Chan L: African American (AA) Renal Transplant One Year Outcomes from the Mycophenolic Acid Observational Renal Transplant (MORE) Registry. Journal of the American Society of Nephrology Nov 2011;22:342A 2011 Narayanan M, Pankewycz O, et al: Enteric-Coated Mycophenolate Sodium (EC-MPS) versus Mycophenolate Mofetil (MMF) in African American (AA) Renal Transplant Recipients from the Mycophenolic Acid Observational Renal Transplant (MORE) Registry. Amer J of Transplantation Apr 2011;Supp 2;11:316-317 2011 May 21, 2017 4

Shihab F, Chan L, Narayanan M, et al: Early Outcome Analysis of the Mycophenolic Acid Observational Renal Transplant (MORE) Registry: Comparisons of Enteric-Coated Mycophenolate Sodium (EC-MPS) and Mycophenolate Mofetil (MMF) in Patients with Diabetes Mellitus (DM) prior to Transplant. Amer J of Transplantation Apr 2011;Supp 2;11:319 2011 Chan L, Irish W, Doria C, Greenstein S, Narayanan M, et al: Distinct Effects of Delayed Graft Function (DGF) and Acute Rejection (BPAR) on Graft Failure (GF) following Kidney Transplantation (KTx): Analysis of the Mycophenolic Acid (MPA) Observational Renal Transplant (MORE) Registry. Amer J of Transplantation May 2010;Supp 4;10:168 2010 Goraya N, Narayanan M: Prediction of Cardiovascular Disease during Pre-Transplant Evaluation. J of Amer Society of Nephrology, Nov 2010;21:329A 2010 Irish W, Doria C, Greenstein S, Chan L, Narayanan M, et al: Durable Dosing Patterns of Mycophenolic Acid (MPA) in Renal Transplantation: Initial Outcome Analysis of the Mycophenolic Acid (MPA) Observational Renal Transplant (MORE) Registry. Amer J of Transplantation May 2010;Supp 4;10:170-171 2010 Langone A, Irish W, Doria C, Greenstein S, Narayanan M, et al: Real- World Calcineurin Inhibitor (CNI) Minimization Strategies: Outcomes Analysis of the Mycophenolic Acid (MPA) Renal Transplant (MORE) Registry. Amer J of Transplantation May 2010;Supp 4;10:509 2010 Narayanan M, Pankewycz O, et al: Enteric-Coated Mycophenolate Sodium (EC-MPS) Versus Mycophenolate Mofetil (MMF) in African American (AA) Renal Transplant Recipients from the Mycophenolic Acid Observational Renal Transplant (MORE) Registry. J of Amer Society of Nephrology Nov 2010;21:325A 2010 May 21, 2017 5

Shihab F, Chan L, Narayanan M, et al: Comparisons of Enteric-Coated Mycophenolate Sodium (EC-MPS) and Mycophenolate Mofetil (MMF) in Renal Transplant Recipients (RTRS) with Diabetes Mellitus (DM) prior to Transplant in the Mycophenolic Acid Observational Renal Transplant (MORE) Registry. J of Amer Society of Nephrology, Nov 2010;21:969A 2010 Goraya N, Narayanan M, Jaffers G: Biopsy Proven BK Polyoma Nephropathy in the Presence of Viruria and Lack of Viremia. American Journal of Transplantation. May 2009;Supp 2;9:426 2009 Irish W, Greenstein S, Doria C, Chan L, Narayanan M, et al: The Mycophenologic Acid Observational Renal Transplant Study (MORE) Registry: Summary of Patient Management in De Novo Renal Transplantation. Amer Journal of Transplantation, May 2009;Supp 2;9:502 2009 Irish W, Doria C, Greenstein S, Chan L, Narayanan M, et al. Mycophenolic Acid (MPA) in Diabetic Kidney Transplant Patients: An Analysis of the MORE Registry. Journal of the Amer Soc of Nephrology, Oct 2009;20:885A-886A 2009 Irish W, Doria C, Greenstein S, Chan L, Narayanan M, et al: Mycophenolic Acid (MPA) Therapy in Kidney Transplantation: An Analysis of the MORE Registry. Journal of the Amer Society of Nephrology Oct 2009;20:573A 2009 Mahajan A, Narayanan M, Concepcion L, Jaffers G: Hypoparathyroidism Associated with Severe Mineral Bone Disease Post Renal Transplantation, Treated Successfully with Recombinant PTH. Hemodialysis International 2009;13(4):547-550 2009 May 21, 2017 6

Mahajan A, Narayanan M, Jaffers G: Atypical Presentation of Cytomegalovirus Colitis in Renal Allograft Recipients. Journal of the Amer Soc of Nephrology Oct 2009;20:897A-898A 2009 Munshi N, Concepcion L, Narayanan M: Primary Hyperoxaluria Causing ESRD and Gangrene of Extremities Leading to Amputations. Hemodialysis International 2009;13(3):266-270 2009 Khurana A, Nickel A, Greene Jr. J, Narayanan M, High W, Foulks C: Successful Pregnancy in a Hemodialysis Patient and Marked Resolution of Her Nephrogenic Systemic Fibrosis. American Journal of Kidney Disease; 51 (6): e29-e32 2008 Khurana A, Nickel A, Narayanan M, Foulks C: Effect of Hepatitis C Infection on Anemia in Hemodialysis Patients. Hemodialysis International; 12 (1): 94-99 2008 Mahajan A, Concepcion L, Narayanan M: Elemental My Dear Watson. Journal of the American Society of Nephrology, Oct 2008;19:939A 2008 Mahajan A, Narayanan M, Song J: Determinants of Immune Function in Renal Transplant Patients. Journal of the American Society of Nephrology, Oct 2008;19:446A 2008 May 21, 2017 7

Munshi N, Concepcion L, Narayanan M: Primary Hyperoxaluria Causing ESRD and Lower Extremity Gangrene. Hemodialysis International; 12 (2): 149 2008 Khurana A, Runge V, Narayanan M, Greene Jr. J, Nickel A: Nephrogenic Systemic Fibrosis: A Review of Six Cases Temporally Related to Gadodiamide Injection (Omniscan). Investigative Radiology Feb.; 42 (2): 139-145 2007 Narayanan M, Szymanski J, Slavcheva E, Rao A, Kelly A, Jones K, Jaffers G: BK Virus Associated Renal Cell Carcinoma: Case Presentation with Optimized PCR and Other Diagnostic Tests. American Journal of Transplantation; 7 (6): 1666-1671 2007 Severson J, Concepcion L, Narayanan, M: Risk factors for BK Virus Infection. Journal of the American Society of Nephrology October; 18: 884A 2007 Severson J, Concepcion L, Narayanan, M: Statin Use Improves Survival Post Kidney Transplantation. Journal of the American Society of Nephrology October; 18: 438A 2007 Khurana A, Foulks, C, Narayanan, M: Post Transplant Anemia: A Single Center Experience. Journal of the American Society of Nephrology November; 17: 860A 2006 May 21, 2017 8

Martin T, Foulks C, Browne B, Narayanan, M: Retrospective Evaluation and Characterization of Health Care Utilization in a Managed Care Organization for Members with Stage 1, 2, or 3 Chronic Kidney Disease. Journal of the American Society of Nephrology November; 17: 646A 2006 Munshi N, Narayanan M: Incidence and Risk Factors for Development of Post Transplant Diabetes Mellitus in Renal Allograft Recipients: A Single-Center Experience. Southern Medical Journal October; 98(10): S64 2005 Narayanan M, Slavcheva E, Rao A, Jones K, Jaffers G: Renal Cell Carcinoma Following BK Virus & SV40 Co-Infection in Polyomavirus Nephropathy. Journal of the American Society of Nephrology October; 15: 869A 2004 Slavcheva E, McCuskey C, Harris D, Narayanan M, Jaffers G: Outcomes of Renal Allograft Biopsy under Direct Ultrasonographic Visualization. Journal of the American Society of Nephrology October; 15: 887A 2004 Slavcheva E, McCuskey C, Fisher M, Atkins M, Narayanan M, Jaffers G: Improvement of Bone Density with Alendronate after Renal Transplantation. American Journal of Transplantation June; Supplement 5; 3: 244A 2003 Slavcheva E, Jaffers G, Narayanan M, Moore C, McCuskey C, Carpenter C: Treatment of CMV Infection in Renal Transplant Recipients with an Abbreviated Course of IV Ganciclovir. Journal of the American Society of Nephrology September; 13: 564A 2002 May 21, 2017 9

Alberto G, Erickson T, Popiel R, Narayanan M, Hryhorczuk D: Central Nervous System Manifestations of a Valproic Acid Overdose Responsive to Naloxone. Annals of Emergency Medicine; 18 (8):889-891 1989 Submitted or in Preparation Martin TM, Browne BA, Foulks CJ, Narayanan M, Powell K. Health care utilization in a managed care setting for members with Stage 1, 2 or 3 chronic kidney disease xxxx May 21, 2017 10